Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai W Wucherpfennig

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Experimental Medicine|January 22, 2004
Presentation of a self-peptide in two distinct conformations by a disease-associated HLA-B27 subtypeKai W Wucherpfennig
Annals of the New York Academy of Sciences|December 18, 2003
MHC-linked susceptibility to type 1 diabetes: a structural perspectiveKai W Wucherpfennig
Molecular Immunology|March 24, 2004
T cell receptor crossreactivity as a general property of T cell recognitionKai W Wucherpfennig
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2010
The first structures of T cell receptors bound to peptide-MHCKai W Wucherpfennig
Nature Medicine|May 2, 2002
Infectious triggers for inflammatory neurological diseasesKai W Wucherpfennig
Annual Review of Immunology|November 29, 2022
Designing Cancer Immunotherapies That Engage T Cells and NK CellsOleksandr Kyrysyuk, Kai W Wucherpfennig
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Tissue-Resident T Cells in Clinical Response and Immune-Related Adverse Events of Immune Checkpoint BlockadeYe Zhao, Kai W Wucherpfennig
Nature Immunology|October 21, 2009
Positively selecting peptides: their job does not end in the thymusKai W Wucherpfennig, Etienne Gagnon
Oncoimmunology|July 23, 2014
Discovering cancer immunotherapy targets in vivoPenghui Zhou, Kai W Wucherpfennig
Current Opinion in Oncology|April 4, 2024
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancerYe Zhao, Kai W Wucherpfennig
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Experimental Medicine|January 22, 2004
Presentation of a self-peptide in two distinct conformations by a disease-associated HLA-B27 subtypeKai W Wucherpfennig
Annals of the New York Academy of Sciences|December 18, 2003
MHC-linked susceptibility to type 1 diabetes: a structural perspectiveKai W Wucherpfennig
Molecular Immunology|March 24, 2004
T cell receptor crossreactivity as a general property of T cell recognitionKai W Wucherpfennig
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2010
The first structures of T cell receptors bound to peptide-MHCKai W Wucherpfennig
Nature Medicine|May 2, 2002
Infectious triggers for inflammatory neurological diseasesKai W Wucherpfennig
Annual Review of Immunology|November 29, 2022
Designing Cancer Immunotherapies That Engage T Cells and NK CellsOleksandr Kyrysyuk, Kai W Wucherpfennig
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Tissue-Resident T Cells in Clinical Response and Immune-Related Adverse Events of Immune Checkpoint BlockadeYe Zhao, Kai W Wucherpfennig
Nature Immunology|October 21, 2009
Positively selecting peptides: their job does not end in the thymusKai W Wucherpfennig, Etienne Gagnon
Oncoimmunology|July 23, 2014
Discovering cancer immunotherapy targets in vivoPenghui Zhou, Kai W Wucherpfennig
Current Opinion in Oncology|April 4, 2024
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancerYe Zhao, Kai W Wucherpfennig
Pageof 19